+Follow
Shihmin
No personal profile
5
Follow
2
Followers
0
Topic
0
Badge
Posts
Hot
Shihmin
2023-04-18
$Citius Pharmaceuticals, Inc.(CTXR)$
Literally my bday today
Shihmin
2023-04-13
I love how easy it is
Shihmin
2023-04-13
Love this new game
@TigerEvents:【Game】Easter Egg Hunting with Tiger, Win Disney Shares and USD 120 Voucher
Shihmin
2023-02-01
Got to be pine apple tarts with milo What are some of your fav cny snacks ?
Shihmin
2022-04-09
$Citius Pharmaceuticals, Inc.(CTXR)$
Buyingthe dip before flying off at 2nd half of 2022
Shihmin
2022-04-05
Looking forward to it
Sorry, the original content has been removed
Shihmin
2021-09-09
True thttt
Is It Safer to Pull Your Money Out of the Stock Market Now?
Shihmin
2021-06-29
$AMC Entertainment(AMC)$
Had to sell because I’m going into ns feels bad.. wanted to hold longerr
Shihmin
2021-06-24
Ok
Pfizer: A Wide Moat Business At A Fair Price
Shihmin
2021-06-15
$AMC Entertainment(AMC)$
Letsgooooo
Shihmin
2021-06-02
$BlackBerry(BB)$
Sheeeejhhh
Shihmin
2021-06-02
Hehe lucky guess ig
Shihmin
2021-05-29
$BlackBerry(BB)$
Huat
Shihmin
2021-05-25
Damn
Toplines Before US Market Open on Tuesday
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":3584091635741664,"uuid":"3584091635741664","gmtCreate":1621008241718,"gmtModify":1623765468753,"name":"Shihmin","pinyin":"shihmin","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":5,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.15","exceedPercentage":"80.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.15","exceedPercentage":"80.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9944153488,"gmtCreate":1681750740845,"gmtModify":1681750744555,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CTXR\">$Citius Pharmaceuticals, Inc.(CTXR)$ </a>Literally my bday today","listText":"<a href=\"https://ttm.financial/S/CTXR\">$Citius Pharmaceuticals, Inc.(CTXR)$ </a>Literally my bday today","text":"$Citius Pharmaceuticals, Inc.(CTXR)$ Literally my bday today","images":[{"img":"https://community-static.tradeup.com/news/a6dcfeab63e37cc51549e3bc4c3f3f8b","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9944153488","isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9945003808,"gmtCreate":1681315933405,"gmtModify":1681315936939,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"I love how easy it is","listText":"I love how easy it is","text":"I love how easy it is","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9945003808","isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9945003923,"gmtCreate":1681315889263,"gmtModify":1681315892918,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Love this new game","listText":"Love this new game","text":"Love this new game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9945003923","repostId":"9943960936","repostType":1,"repost":{"id":9943960936,"gmtCreate":1679046534725,"gmtModify":1680580626622,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/61ed9b39c6cbcdce6372edc1c0b48a2d","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"【Game】Easter Egg Hunting with Tiger, Win Disney Shares and USD 120 Voucher","htmlText":"🐰🌷 Hop into the Easter spirit and join our \"Tiger's Egg Hunting\" game! 🎉Stand to win free Disney stocks and a USD 120 cash voucher!🎁🌟Our interactive Easter game is open to Tigers, and it's so easy to play! Simply jump and catch the egg, and you could be a lucky winner. 🐇That's not all. You can also invite your friends to join in the fun to earn more points. Plus, you can challenge your friends for a race up the leaderboard. Let's fly to the moon together!Don't miss out on this egg-citing opportunity to win BIG! Join the game now and hop on your way to victory. 🥳🐣<a href=\"https://www.tigerbrokers.com.sg/activity/market/2023/easter/?adcode=20230316162207#/\" target=\"_blank\">Join our Easter campaign now</a>","listText":"🐰🌷 Hop into the Easter spirit and join our \"Tiger's Egg Hunting\" game! 🎉Stand to win free Disney stocks and a USD 120 cash voucher!🎁🌟Our interactive Easter game is open to Tigers, and it's so easy to play! Simply jump and catch the egg, and you could be a lucky winner. 🐇That's not all. You can also invite your friends to join in the fun to earn more points. Plus, you can challenge your friends for a race up the leaderboard. Let's fly to the moon together!Don't miss out on this egg-citing opportunity to win BIG! Join the game now and hop on your way to victory. 🥳🐣<a href=\"https://www.tigerbrokers.com.sg/activity/market/2023/easter/?adcode=20230316162207#/\" target=\"_blank\">Join our Easter campaign now</a>","text":"🐰🌷 Hop into the Easter spirit and join our \"Tiger's Egg Hunting\" game! 🎉Stand to win free Disney stocks and a USD 120 cash voucher!🎁🌟Our interactive Easter game is open to Tigers, and it's so easy to play! Simply jump and catch the egg, and you could be a lucky winner. 🐇That's not all. You can also invite your friends to join in the fun to earn more points. Plus, you can challenge your friends for a race up the leaderboard. Let's fly to the moon together!Don't miss out on this egg-citing opportunity to win BIG! Join the game now and hop on your way to victory. 🥳🐣Join our Easter campaign now","images":[{"img":"https://community-static.tradeup.com/news/c90a7371a3bcd1e6c552d2aa23f72c33","width":"1200","height":"630"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943960936","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955392751,"gmtCreate":1675182105774,"gmtModify":1676538982676,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Got to be pine apple tarts with milo What are some of your fav cny snacks ?","listText":"Got to be pine apple tarts with milo What are some of your fav cny snacks ?","text":"Got to be pine apple tarts with milo What are some of your fav cny snacks ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955392751","isVote":1,"tweetType":1,"viewCount":35,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9015135295,"gmtCreate":1649438873075,"gmtModify":1676534512660,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CTXR\">$Citius Pharmaceuticals, Inc.(CTXR)$</a>Buyingthe dip before flying off at 2nd half of 2022","listText":"<a href=\"https://ttm.financial/S/CTXR\">$Citius Pharmaceuticals, Inc.(CTXR)$</a>Buyingthe dip before flying off at 2nd half of 2022","text":"$Citius Pharmaceuticals, Inc.(CTXR)$Buyingthe dip before flying off at 2nd half of 2022","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015135295","isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9016016795,"gmtCreate":1649113217197,"gmtModify":1676534451339,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Looking forward to it ","listText":"Looking forward to it ","text":"Looking forward to it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016016795","repostId":"2223818828","repostType":2,"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883952136,"gmtCreate":1631197917525,"gmtModify":1676530494731,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"True thttt","listText":"True thttt","text":"True thttt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/883952136","repostId":"2166317474","repostType":4,"repost":{"id":"2166317474","pubTimestamp":1631193600,"share":"https://www.laohu8.com/m/news/2166317474?lang=&edition=full","pubTime":"2021-09-09 21:20","market":"us","language":"en","title":"Is It Safer to Pull Your Money Out of the Stock Market Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2166317474","media":"Motley Fool","summary":"If a market downturn is looming, should you withdraw now or stay invested?","content":"<blockquote>\n <b>If a market downturn is looming, should you withdraw now or stay invested?</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Market downturns are normal, but they can still wreak havoc on your investments.</li>\n <li>Pulling your money out may seem like a smart option to keep your savings safe.</li>\n <li>With the right strategy, you can give your investments the best chance at surviving volatility.</li>\n</ul>\n<p>The stock market can be turbulent and unpredictable, and it's sometimes nerve-wracking to invest your life savings. When the market dips, nobody likes seeing their investments take a turn for the worse.</p>\n<p>Although the stock market has been on a remarkable upward trajectory over the past year, it will likely experience a downturn sooner or later. That doesn't necessarily mean the market will crash tomorrow, but ups and downs are normal and to be expected.</p>\n<p>If stock prices do start to fall, pulling your money out of the market may seem like the smartest and safest option. But is that the right move?</p>\n<p><img src=\"https://static.tigerbbs.com/c0d26d0fb6412ce5f2c09582a9085c54\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Just how common are market downturns?</b></p>\n<p>There's no doubt about it: Market downturns are intimidating. Whether you've just started investing or have been buying stocks for decades, few people are truly comfortable with watching their investments plummet in value.</p>\n<p>That said, downturns happen regularly and are not as daunting as they may seem. Since 1928, the <b>S&P 500</b> has experienced 21 separate instances where stock prices fell by more than 20%, according to data from consulting firm Yardeni Research. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> relatively severe downturn approximately every 4.5 years.</p>\n<p>The good news is that regardless of how severe those crashes were, the S&P 500 has recovered from every single one of them so far. If the market does experience another dip, there's a very good chance it will recover once again.</p>\n<p><img src=\"https://static.tigerbbs.com/6f9b2741732af6db7f18c8f6ce721764\" tg-width=\"720\" tg-height=\"410\" referrerpolicy=\"no-referrer\"></p>\n<p>^SPX data by YCharts</p>\n<p><b>Would pulling your money out keep it safer?</b></p>\n<p>Although market downturns are relatively common, it still may seem like a smart idea to pull your money out before prices fall. While that strategy makes sense, it's much tougher to pull off than it may seem.</p>\n<p>It's easy to look back in hindsight and wish you'd pulled your money out of the market right before it crashed. But in the moment, it's nearly impossible to know when, exactly, prices will drop. Market crashes can be unpredictable and unexpected, and even the experts don't always know when they'll happen.</p>\n<p>If you withdraw your money at the wrong time, it could be a costly mistake. Say you're worried the market will crash soon, so you pull all your money out today. But the market doesn't crash, and instead, stock prices continue going up. You decide to reinvest your money, but because prices have increased, you end up paying more for your investments than what you sold them for.</p>\n<p>Or, say you pull your money out of the market but choose not to reinvest because you're worried prices will fall soon. When your money isn't invested, it's not growing as much as it could. And the longer you wait to get started investing again, the more you're limiting your earning potential.</p>\n<p><b>How to keep your investments safe</b></p>\n<p>One of the most important things to remember when investing in the stock market is that you don't lose any money until you sell your stocks. The market could plummet tomorrow, but as long as you don't sell, you haven't lost any money.</p>\n<p>Holding your investments despite market volatility, then, is a smart way to keep your money safer. The market may dip and your stocks may decrease in value, but as long as you're buying the right investments, there's a very good chance they'll recover. When that happens, your portfolio will bounce back stronger than ever.</p>\n<p>Market crashes can be intimidating, but the good news is that they are normal and temporary. By holding your stocks and avoiding the temptation to pull your money out of the market during periods of volatility, you can maximize your earning potential and help your money grow as much as possible.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Safer to Pull Your Money Out of the Stock Market Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Safer to Pull Your Money Out of the Stock Market Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 21:20 GMT+8 <a href=https://www.fool.com/investing/2021/09/09/is-it-safer-to-pull-your-money-out-of-the-stock-ma/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If a market downturn is looming, should you withdraw now or stay invested?\n\nKey Points\n\nMarket downturns are normal, but they can still wreak havoc on your investments.\nPulling your money out may seem...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/09/is-it-safer-to-pull-your-money-out-of-the-stock-ma/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.fool.com/investing/2021/09/09/is-it-safer-to-pull-your-money-out-of-the-stock-ma/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166317474","content_text":"If a market downturn is looming, should you withdraw now or stay invested?\n\nKey Points\n\nMarket downturns are normal, but they can still wreak havoc on your investments.\nPulling your money out may seem like a smart option to keep your savings safe.\nWith the right strategy, you can give your investments the best chance at surviving volatility.\n\nThe stock market can be turbulent and unpredictable, and it's sometimes nerve-wracking to invest your life savings. When the market dips, nobody likes seeing their investments take a turn for the worse.\nAlthough the stock market has been on a remarkable upward trajectory over the past year, it will likely experience a downturn sooner or later. That doesn't necessarily mean the market will crash tomorrow, but ups and downs are normal and to be expected.\nIf stock prices do start to fall, pulling your money out of the market may seem like the smartest and safest option. But is that the right move?\n\nImage source: Getty Images.\nJust how common are market downturns?\nThere's no doubt about it: Market downturns are intimidating. Whether you've just started investing or have been buying stocks for decades, few people are truly comfortable with watching their investments plummet in value.\nThat said, downturns happen regularly and are not as daunting as they may seem. Since 1928, the S&P 500 has experienced 21 separate instances where stock prices fell by more than 20%, according to data from consulting firm Yardeni Research. That's one relatively severe downturn approximately every 4.5 years.\nThe good news is that regardless of how severe those crashes were, the S&P 500 has recovered from every single one of them so far. If the market does experience another dip, there's a very good chance it will recover once again.\n\n^SPX data by YCharts\nWould pulling your money out keep it safer?\nAlthough market downturns are relatively common, it still may seem like a smart idea to pull your money out before prices fall. While that strategy makes sense, it's much tougher to pull off than it may seem.\nIt's easy to look back in hindsight and wish you'd pulled your money out of the market right before it crashed. But in the moment, it's nearly impossible to know when, exactly, prices will drop. Market crashes can be unpredictable and unexpected, and even the experts don't always know when they'll happen.\nIf you withdraw your money at the wrong time, it could be a costly mistake. Say you're worried the market will crash soon, so you pull all your money out today. But the market doesn't crash, and instead, stock prices continue going up. You decide to reinvest your money, but because prices have increased, you end up paying more for your investments than what you sold them for.\nOr, say you pull your money out of the market but choose not to reinvest because you're worried prices will fall soon. When your money isn't invested, it's not growing as much as it could. And the longer you wait to get started investing again, the more you're limiting your earning potential.\nHow to keep your investments safe\nOne of the most important things to remember when investing in the stock market is that you don't lose any money until you sell your stocks. The market could plummet tomorrow, but as long as you don't sell, you haven't lost any money.\nHolding your investments despite market volatility, then, is a smart way to keep your money safer. The market may dip and your stocks may decrease in value, but as long as you're buying the right investments, there's a very good chance they'll recover. When that happens, your portfolio will bounce back stronger than ever.\nMarket crashes can be intimidating, but the good news is that they are normal and temporary. By holding your stocks and avoiding the temptation to pull your money out of the market during periods of volatility, you can maximize your earning potential and help your money grow as much as possible.","news_type":1},"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159569129,"gmtCreate":1624974500461,"gmtModify":1703849199013,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Had to sell because I’m going into ns feels bad.. wanted to hold longerr ","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Had to sell because I’m going into ns feels bad.. wanted to hold longerr ","text":"$AMC Entertainment(AMC)$Had to sell because I’m going into ns feels bad.. wanted to hold longerr","images":[{"img":"https://static.tigerbbs.com/707bf3debc5258e623558ea95a3fb9ad","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/159569129","isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576897924380223","authorId":"3576897924380223","name":"wataru","avatar":"https://static.tigerbbs.com/43453debe7e355c59ebfd4bdf7caa788","crmLevel":2,"crmLevelSwitch":0},"content":"lol 14 dollars for ns?","text":"lol 14 dollars for ns?","html":"lol 14 dollars for ns?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":128561507,"gmtCreate":1624524106709,"gmtModify":1703839273323,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128561507","repostId":"1137537223","repostType":4,"repost":{"id":"1137537223","pubTimestamp":1624523813,"share":"https://www.laohu8.com/m/news/1137537223?lang=&edition=full","pubTime":"2021-06-24 16:36","market":"us","language":"en","title":"Pfizer: A Wide Moat Business At A Fair Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1137537223","media":"seekingalpha","summary":"Summary\n\nAt its current price levels (~$39), an investment in Pfizer represents a wide moat business","content":"<p><b>Summary</b></p>\n<ul>\n <li>At its current price levels (~$39), an investment in Pfizer represents a wide moat business for sale at a fair price.</li>\n <li>The moat is rooted in technological lead, scale, intellectual property, and a strong pipeline.</li>\n <li>As a result, the business enjoys high profitability, return on capital employed, and heathy perpetual growth prospects – the hallmarks of a long-term compounder.</li>\n <li>Investment at the current price provides excellent potential for double-digit return in the long term.</li>\n</ul>\n<p><b>Thesis and Background</b></p>\n<p>The healthcare sector is a great place for value investors, ranging from legends like Warren Buffett to ordinary investors like myself for many good reasons. It caters to fundamental human needs that are not going to change or go away anytime soon. All signs show that the need will only intensify with population growth, longer life expectancy, more interconnected world, et al. The major players like Pfizer Inc (PFE), due to their established lead and scale, are especially well poised to capitalize on such secular trend.</p>\n<p>At its current price levels (~$39), an investment in PFE represents a wide moat business for sale at a fair price. The short-term risk is very manageable given the current entry valuation, the success with their COVID vaccine, and the support from the dividend yield. In the long term, thanks to their profitability and return on capital employed, investment at the current price provides excellent potential for double digit return.</p>\n<p>Before going into any further details, it would help to briefly summarize my investment philosophy to provide a context. I am a long-term, conservative, and value-oriented investor. I hold a rather concentrated portfolio with about a dozen stocks. I rarely buy and very rarely sell. So you will see me writing about a handful of holdings multiple times from different angles. If you like reading in-depth and multifaceted coverage on the same holdings, I am your guy.</p>\n<p>My goal for my stock holdings is to generate<b>D</b>ouble-<b>D</b>igit return during a<b>D</b>ecade, and that is why I nickname my portfolio the DDD portfolio. Currently my portfolio holds the following 9 stocks. Using the date Ifirst publishedthe DDD portfolio on 5/31/2021 as the inception date, its performance on a weekly basis is summarized in the following two charts. It has been a really short time compared to my horizon, but so far so good fortunately.</p>\n<p><img src=\"https://static.tigerbbs.com/4cb3acede81613b3761fd70078b79286\" tg-width=\"640\" tg-height=\"420\"></p>\n<p>Source: Author</p>\n<p><img src=\"https://static.tigerbbs.com/11117eef882381e86fc7ad1e929b15d8\" tg-width=\"640\" tg-height=\"364\" referrerpolicy=\"no-referrer\"></p>\n<p>Source: Author</p>\n<p><b>The businesses and the moat</b></p>\n<p>Pfizer Inc. is a research-based, global biopharmaceutical leader engaged in the discovery, development, manufacture, and distribution of healthcare products. It offers medicines and vaccines in various therapeutic areas, encompassing internal medicine, oncology, vaccines, immunology, rare disease, et al.</p>\n<p>For pharmaceutical companies at this scale, it is all about A) bringing blockbuster drugs (with market value exceeding $1B per year) to market, and B) having a healthy pipeline of potential blockbusters. And PFE is doing a terrific job on both fronts as you can see from the following two charts.</p>\n<p>As seen from the first chart, PFE boasts a collection of blockbuster drugs including Vyndaqel ($1.2B sales in 2020), Prevnar ($5.8B sales), Xeljanz ($2.4B), et al. And in 2021, PFE just added another blockbuster into its production line: the Covid vaccine. PFE was the first to gain FDA approval for its COVID-19 vaccine, and the vaccine is already PFE's top-selling drug as of 2021 Q1. The vaccine brought in $3.4B of sales during 2021 Q1! These blockbuster drugs are about 5 years on average away from patent expiration.</p>\n<p>This where the pipeline comes in. As seen in the second chart, PFE also maintains a healthy pipeline to prepare for the future. This large pipeline consists of ~100 total drugs. The lifecycle for a drug development (from the lab to the market) could take more than a decade. And therefore, the drugs in the later stage of the development, i.e., Phase 3 or later, are more important. And as can be seen, PFE has a total of 33 of them currently. Not all of them will be a blockbuster. And here is how the scale of PFE matters. Thanks to its scale, it does not need all of them to be blockbusters. It can afford the inevitable misses.</p>\n<p><img src=\"https://static.tigerbbs.com/274b7e5bc8ed32603e922232dbdba5d0\" tg-width=\"640\" tg-height=\"349\" referrerpolicy=\"no-referrer\"></p>\n<p>Source:Pfizer 2020 annual report</p>\n<p><img src=\"https://static.tigerbbs.com/8eba34c481717e6f2cfaa6f316498aa2\" tg-width=\"640\" tg-height=\"181\"></p>\n<p>Source: Pfizer 2020 annual report</p>\n<p><b>Profitability and Financial Strength</b></p>\n<p>Thanks to its technological lead and scale, PFE enjoys superior profitability and financial strengths both relative to other peers in the same sector and also to the overall market, as illustrated by the following chart. The profitability is simply superb on every metric - both in absolute terms and in relative terms when compared to its peers.</p>\n<p>The business is also in a very strong financial position, as exemplified by the next chart. Its interest coverage (operation income divided by interest expense) is more than 16x. In other words, it only takes about 6% of its operation income to cover its interest expenses. In contrast, the interest coverage for the overall market represented by S&P 500 is about 6x. Also as shown by the orange line in the chart, thanks to its strong profitability (and terrific return on capital to be detailed later), the business can also afford to pay off pretty much all the remaining income as dividend after covering its debt and maintenance CAPEx.</p>\n<p><img src=\"https://static.tigerbbs.com/2df9ddd5bfc780fb81922d0bf07dfb2f\" tg-width=\"640\" tg-height=\"315\"></p>\n<p>Source: Seeking Alpha.</p>\n<p><img src=\"https://static.tigerbbs.com/b29a25abfa0354c92c5dfb7ab49243ff\" tg-width=\"640\" tg-height=\"398\" referrerpolicy=\"no-referrer\"></p>\n<p>Source: Author based on data from Seeking Alpha</p>\n<p><b>The valuation</b></p>\n<p>As can be seen from the following numbers in the table, at its current price levels, PEF is about fairly valued or slightly discounted depending on which valuation metric you use based on its historical valuations. In terms of absolute valuation, its current valuations (price/cash flow ratio around 14.5x) is also very reasonable for a wide moat business leader. Many consumer staple businesses (like food and drinks business) are valued above 20x cash flow because they cater to an eternal human need. Yet in my view, PFE caters to an equally eternal human need with a wider moat.</p>\n<p>As such, the short-term risk is very manageable given the current entry valuation, especially considering the upcoming boost from their COVID vaccine. And also, the above average dividend yield would help to support the return should any short term turmoil occur.</p>\n<p><img src=\"https://static.tigerbbs.com/28f2c7c3ec96007a14b507da34b0eb02\" tg-width=\"640\" tg-height=\"88\" referrerpolicy=\"no-referrer\">Source: author and Seeking Alpha</p>\n<p><b>Long-term return and perpetual growth rate</b></p>\n<p>If you, like this author, are a long-term investor who subscribes to the concepts of owner's earning, perpetual growth rate, and equity bond, then the long-term return is simpler. It is \"simply\" the summation of the owner's earning yield (\"OEY\") and the perpetual growth rate (\"PGR\"), i.e.,</p>\n<p>Longer-Term ROI = OEY + PGR</p>\n<p>Because in the long term, all fluctuations in valuation are averaged out (all luck at the end even out). And it doesn't really matter how the business uses the earnings (pay out as dividend, retained in the bank account, or repurchase stocks). As long as used sensibly (as PFE has done in the past), it will be reflected as a return to the business owner.</p>\n<p>OEY is the owner's earnings divided by the entry price. All the complications are in the estimation of the owner's earnings - the real economic earnings of the business, not the nominal accounting earnings. Here as a crude and conservative estimate, I will just use the free cash flow (\"FCF\") as the owner's earnings. It is conservative in the sense that rigorously speaking, the owner's earnings should be free cash flow plus the portion of CAPEx that is used to fuel the growth (i.e., the growth CAPEx). At its current price levels, the OEY is ~6.6% for PFE (~15x price to FCF).</p>\n<p>The next and more important item is the PGR. To understand and estimate it, we will need to first estimate the return on capital employed (\"ROCE\"). Note that ROCE is different from the return on equity (and more fundamental and important in my view). ROCE considers the return of capital ACTUALLY employed, and therefore provides insight into how much additional capital a business needs to invest in order to earn a given extra amount of income - a key to estimate the PGR. For businesses like PFE, I consider the following items capital actually employed:</p>\n<p>1. Working capital, including payables, receivables, inventory. These are the capitals required for the daily operation of their businesses.</p>\n<p>2. Gross Property, Plant, and Equipment. These are the capitals required to actually conduct business and manufacture their products.</p>\n<p>3. There are the following two possible routes here:</p>\n<p>3.1. The first route is to include research and development expenses as a capital investment. As mentioned above, the R&D is the lifeblood for a sustainable pharmaceutical business and is not really an optional expense.</p>\n<p>3.2. The second route is to amortize its intangible book value, mainly consisting of intellectual property and patents. This essentially treats the intellectual properties as capital with a finite lifetime, which I will assume to be five years, the average number of years away from its current blockbuster drugs' patent expiration.</p>\n<p>Based on the above considerations, the ROCE of PFE over the past decade are shown below. As seen, both approaches provided similar results, a good sign of the assumptions. PFE was able to maintain a remarkably high and stable ROCE over the long term: on average 44% for the past decade. To put things in perspective, as detailed in myprevious articlesfor Lockheed Martin (LMT) and General Dynamics (GD), ROCEs for these defense business leaders, who almost enjoy a monopoly moat, are \"only\" in the range of 20% to 30%.</p>\n<p><img src=\"https://static.tigerbbs.com/2bcb7c6b4fc7360c3140a7cbcd7aa511\" tg-width=\"640\" tg-height=\"398\"></p>\n<p>Source: Author and Seeking Alpha</p>\n<p>With a 44% ROCE, it means that even if PFE only reinvests 1/10 of its earnings to expand the capital employed, it could maintain a 4.4% PGR (PGR = ROCE * fraction of earnings reinvested = 10% * 44% = 4.4%). And 10% reinvestment rate is indeed the situation here for PFE based on my analyses. As aforementioned, this is a reason that PFE can afford to pay off pretty much all the remaining income as dividend after covering its debt and maintenance CAPEx as dividend (or share repurchase). Of course, another reason is that businesses at this scale simply are not able to find that many opportunities to reinvest their earnings. But after all, 4.4% PGR already makes it a long term compounder with 10% income reinvested!</p>\n<p>Now we have both pieces of the puzzle in place to estimate the long-term return. At its current price levels, the OEY is estimated to be ~6.6% for PFE (~15x price to FCF), and the PGR is about 4.4%. So the total return in the long term at current valuation would be a double digit around 11% as shown in the chart below. Also as seen, even when ROCE fluctuates somewhat, the fluctuations wouldn't change the long-term return dramatically.</p>\n<p><img src=\"https://static.tigerbbs.com/bc98d9c0dd33069c7237e253e96f624b\" tg-width=\"640\" tg-height=\"416\" referrerpolicy=\"no-referrer\"></p>\n<p>Source: Author and Seeking Alpha.</p>\n<p>And for those of us who would like to wait for a better entry price, the next chart shows how much the long-term return potential would change as a function of the entry price. As can be seen, the long-term return potential doesn't change that much within a pretty wide range of entry price, as shown in the green box. This probably confirms something that you've already heard before - if you hold something for the long term, the entry price does not matter that much.</p>\n<p>However, many investors seem to interpret this one-sided and I'd like to do a bit of hairsplitting here. The above statement refers to the long-term RATE of return, not the absolute DOLLAR AMOUNT of return. When your entry price is decreased by 10%, yes, it is correct that this wouldn't impact your long-term rate of return by a lot as seen. But a 10% lower entry price would give you at least 10% more return in absolute dollar amount - because you get to buy 10% more shares with the same dollar amount you have, plus the whatever extra return brought about by the higher RATE of return.</p>\n<p>And as a final note before ending this section, this might be the most valuable insight that I've learned by studying Warren Buffett's investment philosophy. The insight really is that I do not need a business with double-digit growth to generate double-digit returns. A reliable business that can offer a stable growth at a boring rate of a few percent (like ~4% in the examples of PFE) can already provide double-digit returns with good certainty as long as A) they are purchased at a reasonable valuation, and B) they have ROCE sufficiently high so that the growth can be driven by reinvesting a small fraction of the income. In the long run, assuming a growth rate more than a few percent probably is a dangerous assumption to start with anyway.</p>\n<p><img src=\"https://static.tigerbbs.com/cca693c6f94c74a4aebd1de7b8392612\" tg-width=\"640\" tg-height=\"422\"></p>\n<p>Source: Author and Seeking Alpha</p>\n<p><b>Conclusion and final thoughts</b></p>\n<p>The healthcare sector is a great place for value investors and enjoys long-term secular headwinds. Major players like Pfizer, due to their established lead and scale, are especially well-poised to capitalize on such secular trend. At its current price levels (~$39), an investment in PFE represents a wide moat business for sale at a fair price. The short-term risk is very manageable given the current entry valuation, the success with their COVID vaccine, and the support from the dividend yield. In the long term, the business features all the hallmarks of a long-term compounder - high profitability, high return on capital employed, and healthy perpetual growth prospects. An investment at the current price provides excellent potential for double-digit return in the long term.</p>\n<p>I am not buying only because my portfolio already holds enough healthcare stocks, which have similar return/risk profiles as I see. I just cannot have all of them and have to choose.</p>\n<p>Thanks for reading! And look forward to hearing your thoughts and comments.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer: A Wide Moat Business At A Fair Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer: A Wide Moat Business At A Fair Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 16:36 GMT+8 <a href=https://seekingalpha.com/article/4436314-pfizer-wide-moat-business-fair-price><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAt its current price levels (~$39), an investment in Pfizer represents a wide moat business for sale at a fair price.\nThe moat is rooted in technological lead, scale, intellectual property, ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436314-pfizer-wide-moat-business-fair-price\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://seekingalpha.com/article/4436314-pfizer-wide-moat-business-fair-price","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1137537223","content_text":"Summary\n\nAt its current price levels (~$39), an investment in Pfizer represents a wide moat business for sale at a fair price.\nThe moat is rooted in technological lead, scale, intellectual property, and a strong pipeline.\nAs a result, the business enjoys high profitability, return on capital employed, and heathy perpetual growth prospects – the hallmarks of a long-term compounder.\nInvestment at the current price provides excellent potential for double-digit return in the long term.\n\nThesis and Background\nThe healthcare sector is a great place for value investors, ranging from legends like Warren Buffett to ordinary investors like myself for many good reasons. It caters to fundamental human needs that are not going to change or go away anytime soon. All signs show that the need will only intensify with population growth, longer life expectancy, more interconnected world, et al. The major players like Pfizer Inc (PFE), due to their established lead and scale, are especially well poised to capitalize on such secular trend.\nAt its current price levels (~$39), an investment in PFE represents a wide moat business for sale at a fair price. The short-term risk is very manageable given the current entry valuation, the success with their COVID vaccine, and the support from the dividend yield. In the long term, thanks to their profitability and return on capital employed, investment at the current price provides excellent potential for double digit return.\nBefore going into any further details, it would help to briefly summarize my investment philosophy to provide a context. I am a long-term, conservative, and value-oriented investor. I hold a rather concentrated portfolio with about a dozen stocks. I rarely buy and very rarely sell. So you will see me writing about a handful of holdings multiple times from different angles. If you like reading in-depth and multifaceted coverage on the same holdings, I am your guy.\nMy goal for my stock holdings is to generateDouble-Digit return during aDecade, and that is why I nickname my portfolio the DDD portfolio. Currently my portfolio holds the following 9 stocks. Using the date Ifirst publishedthe DDD portfolio on 5/31/2021 as the inception date, its performance on a weekly basis is summarized in the following two charts. It has been a really short time compared to my horizon, but so far so good fortunately.\n\nSource: Author\n\nSource: Author\nThe businesses and the moat\nPfizer Inc. is a research-based, global biopharmaceutical leader engaged in the discovery, development, manufacture, and distribution of healthcare products. It offers medicines and vaccines in various therapeutic areas, encompassing internal medicine, oncology, vaccines, immunology, rare disease, et al.\nFor pharmaceutical companies at this scale, it is all about A) bringing blockbuster drugs (with market value exceeding $1B per year) to market, and B) having a healthy pipeline of potential blockbusters. And PFE is doing a terrific job on both fronts as you can see from the following two charts.\nAs seen from the first chart, PFE boasts a collection of blockbuster drugs including Vyndaqel ($1.2B sales in 2020), Prevnar ($5.8B sales), Xeljanz ($2.4B), et al. And in 2021, PFE just added another blockbuster into its production line: the Covid vaccine. PFE was the first to gain FDA approval for its COVID-19 vaccine, and the vaccine is already PFE's top-selling drug as of 2021 Q1. The vaccine brought in $3.4B of sales during 2021 Q1! These blockbuster drugs are about 5 years on average away from patent expiration.\nThis where the pipeline comes in. As seen in the second chart, PFE also maintains a healthy pipeline to prepare for the future. This large pipeline consists of ~100 total drugs. The lifecycle for a drug development (from the lab to the market) could take more than a decade. And therefore, the drugs in the later stage of the development, i.e., Phase 3 or later, are more important. And as can be seen, PFE has a total of 33 of them currently. Not all of them will be a blockbuster. And here is how the scale of PFE matters. Thanks to its scale, it does not need all of them to be blockbusters. It can afford the inevitable misses.\n\nSource:Pfizer 2020 annual report\n\nSource: Pfizer 2020 annual report\nProfitability and Financial Strength\nThanks to its technological lead and scale, PFE enjoys superior profitability and financial strengths both relative to other peers in the same sector and also to the overall market, as illustrated by the following chart. The profitability is simply superb on every metric - both in absolute terms and in relative terms when compared to its peers.\nThe business is also in a very strong financial position, as exemplified by the next chart. Its interest coverage (operation income divided by interest expense) is more than 16x. In other words, it only takes about 6% of its operation income to cover its interest expenses. In contrast, the interest coverage for the overall market represented by S&P 500 is about 6x. Also as shown by the orange line in the chart, thanks to its strong profitability (and terrific return on capital to be detailed later), the business can also afford to pay off pretty much all the remaining income as dividend after covering its debt and maintenance CAPEx.\n\nSource: Seeking Alpha.\n\nSource: Author based on data from Seeking Alpha\nThe valuation\nAs can be seen from the following numbers in the table, at its current price levels, PEF is about fairly valued or slightly discounted depending on which valuation metric you use based on its historical valuations. In terms of absolute valuation, its current valuations (price/cash flow ratio around 14.5x) is also very reasonable for a wide moat business leader. Many consumer staple businesses (like food and drinks business) are valued above 20x cash flow because they cater to an eternal human need. Yet in my view, PFE caters to an equally eternal human need with a wider moat.\nAs such, the short-term risk is very manageable given the current entry valuation, especially considering the upcoming boost from their COVID vaccine. And also, the above average dividend yield would help to support the return should any short term turmoil occur.\nSource: author and Seeking Alpha\nLong-term return and perpetual growth rate\nIf you, like this author, are a long-term investor who subscribes to the concepts of owner's earning, perpetual growth rate, and equity bond, then the long-term return is simpler. It is \"simply\" the summation of the owner's earning yield (\"OEY\") and the perpetual growth rate (\"PGR\"), i.e.,\nLonger-Term ROI = OEY + PGR\nBecause in the long term, all fluctuations in valuation are averaged out (all luck at the end even out). And it doesn't really matter how the business uses the earnings (pay out as dividend, retained in the bank account, or repurchase stocks). As long as used sensibly (as PFE has done in the past), it will be reflected as a return to the business owner.\nOEY is the owner's earnings divided by the entry price. All the complications are in the estimation of the owner's earnings - the real economic earnings of the business, not the nominal accounting earnings. Here as a crude and conservative estimate, I will just use the free cash flow (\"FCF\") as the owner's earnings. It is conservative in the sense that rigorously speaking, the owner's earnings should be free cash flow plus the portion of CAPEx that is used to fuel the growth (i.e., the growth CAPEx). At its current price levels, the OEY is ~6.6% for PFE (~15x price to FCF).\nThe next and more important item is the PGR. To understand and estimate it, we will need to first estimate the return on capital employed (\"ROCE\"). Note that ROCE is different from the return on equity (and more fundamental and important in my view). ROCE considers the return of capital ACTUALLY employed, and therefore provides insight into how much additional capital a business needs to invest in order to earn a given extra amount of income - a key to estimate the PGR. For businesses like PFE, I consider the following items capital actually employed:\n1. Working capital, including payables, receivables, inventory. These are the capitals required for the daily operation of their businesses.\n2. Gross Property, Plant, and Equipment. These are the capitals required to actually conduct business and manufacture their products.\n3. There are the following two possible routes here:\n3.1. The first route is to include research and development expenses as a capital investment. As mentioned above, the R&D is the lifeblood for a sustainable pharmaceutical business and is not really an optional expense.\n3.2. The second route is to amortize its intangible book value, mainly consisting of intellectual property and patents. This essentially treats the intellectual properties as capital with a finite lifetime, which I will assume to be five years, the average number of years away from its current blockbuster drugs' patent expiration.\nBased on the above considerations, the ROCE of PFE over the past decade are shown below. As seen, both approaches provided similar results, a good sign of the assumptions. PFE was able to maintain a remarkably high and stable ROCE over the long term: on average 44% for the past decade. To put things in perspective, as detailed in myprevious articlesfor Lockheed Martin (LMT) and General Dynamics (GD), ROCEs for these defense business leaders, who almost enjoy a monopoly moat, are \"only\" in the range of 20% to 30%.\n\nSource: Author and Seeking Alpha\nWith a 44% ROCE, it means that even if PFE only reinvests 1/10 of its earnings to expand the capital employed, it could maintain a 4.4% PGR (PGR = ROCE * fraction of earnings reinvested = 10% * 44% = 4.4%). And 10% reinvestment rate is indeed the situation here for PFE based on my analyses. As aforementioned, this is a reason that PFE can afford to pay off pretty much all the remaining income as dividend after covering its debt and maintenance CAPEx as dividend (or share repurchase). Of course, another reason is that businesses at this scale simply are not able to find that many opportunities to reinvest their earnings. But after all, 4.4% PGR already makes it a long term compounder with 10% income reinvested!\nNow we have both pieces of the puzzle in place to estimate the long-term return. At its current price levels, the OEY is estimated to be ~6.6% for PFE (~15x price to FCF), and the PGR is about 4.4%. So the total return in the long term at current valuation would be a double digit around 11% as shown in the chart below. Also as seen, even when ROCE fluctuates somewhat, the fluctuations wouldn't change the long-term return dramatically.\n\nSource: Author and Seeking Alpha.\nAnd for those of us who would like to wait for a better entry price, the next chart shows how much the long-term return potential would change as a function of the entry price. As can be seen, the long-term return potential doesn't change that much within a pretty wide range of entry price, as shown in the green box. This probably confirms something that you've already heard before - if you hold something for the long term, the entry price does not matter that much.\nHowever, many investors seem to interpret this one-sided and I'd like to do a bit of hairsplitting here. The above statement refers to the long-term RATE of return, not the absolute DOLLAR AMOUNT of return. When your entry price is decreased by 10%, yes, it is correct that this wouldn't impact your long-term rate of return by a lot as seen. But a 10% lower entry price would give you at least 10% more return in absolute dollar amount - because you get to buy 10% more shares with the same dollar amount you have, plus the whatever extra return brought about by the higher RATE of return.\nAnd as a final note before ending this section, this might be the most valuable insight that I've learned by studying Warren Buffett's investment philosophy. The insight really is that I do not need a business with double-digit growth to generate double-digit returns. A reliable business that can offer a stable growth at a boring rate of a few percent (like ~4% in the examples of PFE) can already provide double-digit returns with good certainty as long as A) they are purchased at a reasonable valuation, and B) they have ROCE sufficiently high so that the growth can be driven by reinvesting a small fraction of the income. In the long run, assuming a growth rate more than a few percent probably is a dangerous assumption to start with anyway.\n\nSource: Author and Seeking Alpha\nConclusion and final thoughts\nThe healthcare sector is a great place for value investors and enjoys long-term secular headwinds. Major players like Pfizer, due to their established lead and scale, are especially well-poised to capitalize on such secular trend. At its current price levels (~$39), an investment in PFE represents a wide moat business for sale at a fair price. The short-term risk is very manageable given the current entry valuation, the success with their COVID vaccine, and the support from the dividend yield. In the long term, the business features all the hallmarks of a long-term compounder - high profitability, high return on capital employed, and healthy perpetual growth prospects. An investment at the current price provides excellent potential for double-digit return in the long term.\nI am not buying only because my portfolio already holds enough healthcare stocks, which have similar return/risk profiles as I see. I just cannot have all of them and have to choose.\nThanks for reading! And look forward to hearing your thoughts and comments.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160022886,"gmtCreate":1623767180045,"gmtModify":1703818792169,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Letsgooooo","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Letsgooooo","text":"$AMC Entertainment(AMC)$Letsgooooo","images":[{"img":"https://static.tigerbbs.com/653d75ebcacb49de46056db5139d61a5","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160022886","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":113630398,"gmtCreate":1622608537414,"gmtModify":1704187270422,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Sheeeejhhh","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Sheeeejhhh","text":"$BlackBerry(BB)$Sheeeejhhh","images":[{"img":"https://static.tigerbbs.com/218c1daabb4cf94d768d1eb46643bbd8","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113630398","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":113605797,"gmtCreate":1622607774519,"gmtModify":1704187253370,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hehe lucky guess ig","listText":"Hehe lucky guess ig","text":"Hehe lucky guess ig","images":[{"img":"https://static.tigerbbs.com/d95a410e904d84add3404148db77bf59","width":"825","height":"1351"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113605797","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":134623697,"gmtCreate":1622224378119,"gmtModify":1704181900610,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Huat","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Huat","text":"$BlackBerry(BB)$Huat","images":[{"img":"https://static.tigerbbs.com/56b0f646e71e392645fb555431c48e56","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134623697","isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":138247763,"gmtCreate":1621946569652,"gmtModify":1704364907341,"author":{"id":"3584091635741664","authorId":"3584091635741664","name":"Shihmin","avatar":"https://static.tigerbbs.com/aef10758a3363503ae77752414725731","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Damn ","listText":"Damn ","text":"Damn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/138247763","repostId":"1140046763","repostType":4,"repost":{"id":"1140046763","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1621944646,"share":"https://www.laohu8.com/m/news/1140046763?lang=&edition=full","pubTime":"2021-05-25 20:10","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1140046763","media":"Tiger Newspress","summary":"U.S. stock index futures rose on Tuesday, buoyed by gains in mega-cap technology-related stocks as i","content":"<p>U.S. stock index futures rose on Tuesday, buoyed by gains in mega-cap technology-related stocks as inflation worries ebbed and U.S. bond yields eased for the fourth straight day.</p><p>At 8:05 a.m. ET, Dow E-minis were up 93 points, or 0.27%, S&P 500 E-minis were up 14.5 points, or 0.35% and Nasdaq 100 E-minis were up 80.5 points, or 0.59%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0cb3de938a9511fee104454b3e726612\" tg-width=\"818\" tg-height=\"278\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p><p>Apple Inc, Amazon.com Inc, Microsoft Corp and Alphabet Inc added between 0.4% and 1% in premarket trading as the yield on 10-year bond slipped to a fresh two-week low on Tuesday.</p><p>Higher yields pressure valuations for tech and other growth stocks, whose future cash flows are discounted at higher rates.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><b>Moderna(MRNA)</b>-Moderna rose 2.33% in premarket trading after its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer's to demonstrate high efficacy in younger age groups.</p><p><b>Lordstown Motors(RIDE)</b> – Lordstown tumbled 13.7% in premarket trading after the electric vehicle startupsaid it needed to raise capitalto fund operations and that its production this year would be, at best, 50% of prior projections.</p><p><b>Canopy Growth(CGC) </b>– The cannabis producer’s shares rose 2.4% in the premarket after MKM Partners upgraded the stock to “buy” from “neutral.” MKM said sentiment surrounding the stock is so low that the current risk/reward profile is very favorable.</p><p><b>Shake Shack(SHAK)</b> – The restaurant chain’s stock rallied 5.2% in premarket trading after Goldman Sachs upgraded it to “buy” from “neutral.” Goldman believes a recent pullback presents a buying opportunity, given Shake Shack’s strong balance sheet and favorable long-term growth prospects. Additionally, Wedbush upgraded the stock to “outperform” from “neutral,” citing similar reasons.</p><p><b>AutoZone(AZO)</b> – The auto parts retailer reported quarterly profit of $26.48 per share, beating the consensus estimate of $20.14 a share. Revenue also came in above estimates. Comparable-store sales surged 28.9%, well above the consensus FactSet estimate of 17.1%. AutoZone’s gross margins dropped, however, due in part to an acceleration of the company’s commercial business. AutoZone added 1.1% in premarket trading.</p><p><b>Amazon(AMZN)</b> – Amazon could announcea deal to buy MGM Studiosas soon as this week, according to a person familiar with the matter who spoke to CNBC. The projected price of up to $9 billion would make this Amazon’s largest acquisition since it bought Whole Foods in 2017 for $13.7 billion.</p><p><b>AstraZeneca(AZN)</b> – AstraZeneca’s $39 billion takeover of U.S. drugmakerAlexion Pharmaceuticals(ALXN) is the subject of a probe by British competition regulators, who want to determine if the deal will reduce competition in the U.K. and elsewhere.</p><p><b>United Airlines(UAL)</b> – United said in a Securities and Exchange Commission filing that ticketed yields have accelerated during the second quarter ahead of its prior projections. It now sees the key metric of revenue per available seat mile falling about 12% this quarter compared to its prior estimate of a 20% drop.</p><p><b>Live Nation Entertainment(LYV)</b> – Live Nation President Joe Berchtold told CNBC’s “Closing Bell” that concert venue bookings are rebounding, and that it is expecting a better year in 2022 than it had in 2019. Shares added 1% in premarket action.</p><p><b>IAC/Interactive(IAC) </b>– IAC shares jumped 5.3% in premarket trading ahead of today’s spinoff of Vimeo to IAC shareholders. Vimeo will begin trading on the Nasdaq today, with the producer of video tools valued at roughly $10 billion.</p><p><b>Petco(WOOF) </b>– The pet products retailer announced a secondary stock offering of 22 million shares, with the selling stockholder granting underwriters the option to purchase another 3.3 million shares within 30 days. Petco will not receive any proceeds from the offering. The stock fell 1.1% in the premarket.</p><p><b>Alaska Air(ALK)</b> – Alaska Air boosted its cash flow outlook for the current quarter, saying it now expects positive cash flow of $550 million to $650 million compared to a prior projection of $450 million to $550 million. The airline cites improved travel demand as well as better-than-expected affinity card inflows. Alaska Air shares fell 2.8% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-25 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures rose on Tuesday, buoyed by gains in mega-cap technology-related stocks as inflation worries ebbed and U.S. bond yields eased for the fourth straight day.</p><p>At 8:05 a.m. ET, Dow E-minis were up 93 points, or 0.27%, S&P 500 E-minis were up 14.5 points, or 0.35% and Nasdaq 100 E-minis were up 80.5 points, or 0.59%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0cb3de938a9511fee104454b3e726612\" tg-width=\"818\" tg-height=\"278\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p><p>Apple Inc, Amazon.com Inc, Microsoft Corp and Alphabet Inc added between 0.4% and 1% in premarket trading as the yield on 10-year bond slipped to a fresh two-week low on Tuesday.</p><p>Higher yields pressure valuations for tech and other growth stocks, whose future cash flows are discounted at higher rates.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><b>Moderna(MRNA)</b>-Moderna rose 2.33% in premarket trading after its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer's to demonstrate high efficacy in younger age groups.</p><p><b>Lordstown Motors(RIDE)</b> – Lordstown tumbled 13.7% in premarket trading after the electric vehicle startupsaid it needed to raise capitalto fund operations and that its production this year would be, at best, 50% of prior projections.</p><p><b>Canopy Growth(CGC) </b>– The cannabis producer’s shares rose 2.4% in the premarket after MKM Partners upgraded the stock to “buy” from “neutral.” MKM said sentiment surrounding the stock is so low that the current risk/reward profile is very favorable.</p><p><b>Shake Shack(SHAK)</b> – The restaurant chain’s stock rallied 5.2% in premarket trading after Goldman Sachs upgraded it to “buy” from “neutral.” Goldman believes a recent pullback presents a buying opportunity, given Shake Shack’s strong balance sheet and favorable long-term growth prospects. Additionally, Wedbush upgraded the stock to “outperform” from “neutral,” citing similar reasons.</p><p><b>AutoZone(AZO)</b> – The auto parts retailer reported quarterly profit of $26.48 per share, beating the consensus estimate of $20.14 a share. Revenue also came in above estimates. Comparable-store sales surged 28.9%, well above the consensus FactSet estimate of 17.1%. AutoZone’s gross margins dropped, however, due in part to an acceleration of the company’s commercial business. AutoZone added 1.1% in premarket trading.</p><p><b>Amazon(AMZN)</b> – Amazon could announcea deal to buy MGM Studiosas soon as this week, according to a person familiar with the matter who spoke to CNBC. The projected price of up to $9 billion would make this Amazon’s largest acquisition since it bought Whole Foods in 2017 for $13.7 billion.</p><p><b>AstraZeneca(AZN)</b> – AstraZeneca’s $39 billion takeover of U.S. drugmakerAlexion Pharmaceuticals(ALXN) is the subject of a probe by British competition regulators, who want to determine if the deal will reduce competition in the U.K. and elsewhere.</p><p><b>United Airlines(UAL)</b> – United said in a Securities and Exchange Commission filing that ticketed yields have accelerated during the second quarter ahead of its prior projections. It now sees the key metric of revenue per available seat mile falling about 12% this quarter compared to its prior estimate of a 20% drop.</p><p><b>Live Nation Entertainment(LYV)</b> – Live Nation President Joe Berchtold told CNBC’s “Closing Bell” that concert venue bookings are rebounding, and that it is expecting a better year in 2022 than it had in 2019. Shares added 1% in premarket action.</p><p><b>IAC/Interactive(IAC) </b>– IAC shares jumped 5.3% in premarket trading ahead of today’s spinoff of Vimeo to IAC shareholders. Vimeo will begin trading on the Nasdaq today, with the producer of video tools valued at roughly $10 billion.</p><p><b>Petco(WOOF) </b>– The pet products retailer announced a secondary stock offering of 22 million shares, with the selling stockholder granting underwriters the option to purchase another 3.3 million shares within 30 days. Petco will not receive any proceeds from the offering. The stock fell 1.1% in the premarket.</p><p><b>Alaska Air(ALK)</b> – Alaska Air boosted its cash flow outlook for the current quarter, saying it now expects positive cash flow of $550 million to $650 million compared to a prior projection of $450 million to $550 million. The airline cites improved travel demand as well as better-than-expected affinity card inflows. Alaska Air shares fell 2.8% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140046763","content_text":"U.S. stock index futures rose on Tuesday, buoyed by gains in mega-cap technology-related stocks as inflation worries ebbed and U.S. bond yields eased for the fourth straight day.At 8:05 a.m. ET, Dow E-minis were up 93 points, or 0.27%, S&P 500 E-minis were up 14.5 points, or 0.35% and Nasdaq 100 E-minis were up 80.5 points, or 0.59%.*Source From Tiger Trade, EST 08:05Apple Inc, Amazon.com Inc, Microsoft Corp and Alphabet Inc added between 0.4% and 1% in premarket trading as the yield on 10-year bond slipped to a fresh two-week low on Tuesday.Higher yields pressure valuations for tech and other growth stocks, whose future cash flows are discounted at higher rates.Stocks making the biggest moves in the premarket:Moderna(MRNA)-Moderna rose 2.33% in premarket trading after its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer's to demonstrate high efficacy in younger age groups.Lordstown Motors(RIDE) – Lordstown tumbled 13.7% in premarket trading after the electric vehicle startupsaid it needed to raise capitalto fund operations and that its production this year would be, at best, 50% of prior projections.Canopy Growth(CGC) – The cannabis producer’s shares rose 2.4% in the premarket after MKM Partners upgraded the stock to “buy” from “neutral.” MKM said sentiment surrounding the stock is so low that the current risk/reward profile is very favorable.Shake Shack(SHAK) – The restaurant chain’s stock rallied 5.2% in premarket trading after Goldman Sachs upgraded it to “buy” from “neutral.” Goldman believes a recent pullback presents a buying opportunity, given Shake Shack’s strong balance sheet and favorable long-term growth prospects. Additionally, Wedbush upgraded the stock to “outperform” from “neutral,” citing similar reasons.AutoZone(AZO) – The auto parts retailer reported quarterly profit of $26.48 per share, beating the consensus estimate of $20.14 a share. Revenue also came in above estimates. Comparable-store sales surged 28.9%, well above the consensus FactSet estimate of 17.1%. AutoZone’s gross margins dropped, however, due in part to an acceleration of the company’s commercial business. AutoZone added 1.1% in premarket trading.Amazon(AMZN) – Amazon could announcea deal to buy MGM Studiosas soon as this week, according to a person familiar with the matter who spoke to CNBC. The projected price of up to $9 billion would make this Amazon’s largest acquisition since it bought Whole Foods in 2017 for $13.7 billion.AstraZeneca(AZN) – AstraZeneca’s $39 billion takeover of U.S. drugmakerAlexion Pharmaceuticals(ALXN) is the subject of a probe by British competition regulators, who want to determine if the deal will reduce competition in the U.K. and elsewhere.United Airlines(UAL) – United said in a Securities and Exchange Commission filing that ticketed yields have accelerated during the second quarter ahead of its prior projections. It now sees the key metric of revenue per available seat mile falling about 12% this quarter compared to its prior estimate of a 20% drop.Live Nation Entertainment(LYV) – Live Nation President Joe Berchtold told CNBC’s “Closing Bell” that concert venue bookings are rebounding, and that it is expecting a better year in 2022 than it had in 2019. Shares added 1% in premarket action.IAC/Interactive(IAC) – IAC shares jumped 5.3% in premarket trading ahead of today’s spinoff of Vimeo to IAC shareholders. Vimeo will begin trading on the Nasdaq today, with the producer of video tools valued at roughly $10 billion.Petco(WOOF) – The pet products retailer announced a secondary stock offering of 22 million shares, with the selling stockholder granting underwriters the option to purchase another 3.3 million shares within 30 days. Petco will not receive any proceeds from the offering. The stock fell 1.1% in the premarket.Alaska Air(ALK) – Alaska Air boosted its cash flow outlook for the current quarter, saying it now expects positive cash flow of $550 million to $650 million compared to a prior projection of $450 million to $550 million. The airline cites improved travel demand as well as better-than-expected affinity card inflows. Alaska Air shares fell 2.8% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[],"lives":[]}